KZA 0.00% 8.0¢ kazia therapeutics limited

Unravelling glioblastoma’s secrets and harnessing two decades of progress, page-4

  1. 1,282 Posts.
    lightbulb Created with Sketch. 243
    The journey we were on with GBM was:
    Disease Area Newly diagnosed glioblastoma with unmethylated MGMT promotor status (representing resistance to temozolomide)
    So lets see what the results say?
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.